Αναζήτηση

πρόσθεσε ένα νέο άρθρο άλλο

2026-10-14 07:59:06 -

Peptide Therapeutics Market: Why In-House Manufacturing Still Leads at 64.8%

How large can a drug class get once it proves it can treat obesity, diabetes and heart risk at the same time? The peptide therapeutics market offers an early answer. Valued at USD 140.9 billion in 2025, it is projected to reach USD 294.6 billion by 2033, growing at 8.7% annually from 2026. North America accounts for 61.9% of today’s revenue, but the factors that decide the next USD 130...

0 Σχόλια 0 Μοιράστηκε 590 Views 0 Προεπισκόπηση